Department of Cell Biology and Physiology, University of North Carolina, Chapel Hill, North Carolina 27599, USA; email:
Annu Rev Med. 2021 Jan 27;72:167-182. doi: 10.1146/annurev-med-051419-114417.
The lymphatic system has received increasing scientific and clinical attention because a wide variety of diseases are linked to lymphatic pathologies and because the lymphatic system serves as an ideal conduit for drug delivery. Lymphatic vessels exert heterogeneous roles in different organs and vascular beds, and consequently, their dysfunction leads to distinct organ-specific outcomes. Although studies in animal model systems have led to the identification of crucial lymphatic genes with potential therapeutic benefit, effective lymphatic-targeted therapeutics are currently lacking for human lymphatic pathological conditions. Here, we focus on the therapeutic roles of lymphatic vessels in diseases and summarize the promising therapeutic targets for modulating lymphangiogenesis or lymphatic function in preclinical or clinical settings. We also discuss considerations for drug delivery or targeting of lymphatic vessels for treatment of lymphatic-related diseases. The lymphatic vasculature is rapidly emerging as a critical system for targeted modulation of its function and as a vehicle for innovative drug delivery.
淋巴系统受到越来越多的科学和临床关注,因为各种疾病都与淋巴病理有关,而且淋巴系统是药物输送的理想途径。淋巴血管在不同的器官和血管床中发挥着不同的作用,因此它们的功能障碍会导致特定的器官特异性结果。尽管动物模型系统的研究已经确定了具有潜在治疗益处的关键淋巴基因,但目前还缺乏针对人类淋巴病理状况的有效的淋巴靶向治疗方法。在这里,我们专注于淋巴血管在疾病中的治疗作用,并总结了在临床前或临床环境中调节淋巴管生成或淋巴功能的有前途的治疗靶点。我们还讨论了用于治疗与淋巴相关疾病的药物输送或淋巴血管靶向的考虑因素。淋巴脉管系统正在迅速成为靶向调节其功能的关键系统,也是创新药物输送的载体。